Skip to main content
. 2021 Jul 25;9(8):821. doi: 10.3390/vaccines9080821

Table 1.

Overall and NOS-grouped effect sizes, including parameters of the strength of evidence, robustness, and prediction interval.

Studies’ NOS 1-Scaled Groups Pooled ES 2 (95% CI 3) * No Serious Publication Bias (Pooled ES; 95% CI) ** 95% Prediction Interval Number of MAs 4 No Serious Studies’ Inconsistency (I2) 5 No Serious Impression (SE) 6 Power of Test (%) Robustness
2 0.95 (0.58–1.57) Yes (0.95; 0.58–1.57) 0.02–39.1 2 Yes (0.0%) No (0.25) - NA 8
3 2.55 (0.99–6.52) No (5.25; 4.61–5.97) 0.03–194 9 No (97.7%) No (0.48) 43.3 NA
4 1.01 (0.72–1.41) No (1.16; 1.03–1.31) 0.10–10.0 43 No (84.8%) No (0.17) 8.5 NA
5 1.33 (1.13–1.56) Yes (1.10; 1.02–1.18) 0.43–4.14 90 No (62.1%) Yes (0.08) 83.0 NA
6 0.99 (0.89–1.09) No (1.04; 1.01–1.07) 0.59–1.66 54 No (72.3%) Yes (0.05) 92.0 NA
7 0.98 (0.92–1.04) Yes (0.95; 0.91–0.98) 0.63–1.51 105 Yes (47.1%) Yes (0.03) 99.3 NA
8 1.00 (0.96–1.05) Yes (1.01; 0.98–1.04) 0.74–1.36 159 Yes (34.5%) Yes (0.02) >99.9 NA
9 1.00 (0.95–1.06) Yes (0.93; 0.91–0.95) 0.72–1.40 100 Yes (48.0%) Yes (0.03) 99.6 NA
Overall, any RoB 7 1.05 (1.01–1.09) No (1.00; 0.99–1.02) 0.55–1.99 562 No (76.3%) Yes (0.02) 90.7 NA
Overall, low RoB 0.99 (0.97–1.02) Yes (0.96; 0.95–0.98) 0.73–1.36 364 Yes (44.1%) Yes (0.02) >99.9 Yes

1 NOS: Newcastle–Ottawa Scale; 2 ES: effect size, 3 CI: confidence interval; 4 MAs: measures of association; 5 I2: index of inconsistency; 6 SE: standard deviation; 7 RoB: risk of bias; 8 NA: not applicable; *: pooled effect size derived from the random-effects model including 95% confidence interval; and **: pooled effect size derived from the fixed-effects model including 95% confidence interval.